Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-01 @ 10:24 PM
Study NCT ID:
NCT05261269
Status:
COMPLETED
Last Update Posted:
2023-12-13
First Post:
2022-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer
Sponsor:
Dantari, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-15
First Submit QC Date:
None
Study First Post Date:
2022-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-07
Last Update Post Date:
2023-12-13
Last Update Post Date Type:
ACTUAL